1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 689 F.Supp.2d
  5. 689 F.Supp.2d 174 (2010)
 

ACTAVIS ELIZABETH LLC v. U.S. FOOD & DRUG ADMIN.

Civil Action No. 09-362(RMC).

689 F.Supp.2d 174 (2010)

ACTAVIS ELIZABETH LLC, Plaintiff, v. UNITED STATES FOOD & DRUG ADMINISTRATION, et al., Defendants.

United States District Court, District of Columbia.

March 4, 2010.

Attorney(s) appearing for the Case

James David Veltrop, Chad A. Landmon, Jo Anne M. Kokoski, Axinn, Veltrop & Harkrider, L.L.P., Hartford, CT, Robert B. Greenbaum, Axinn Veltrop & Harkrider LLP, Washington, DC, for Plaintiff.

Andrew E. Clark, US Department of Justice, Office of Consumer Litigation, Washington, DC, for Defendants.

George F. Pappas, Peter O. Safir, Emily Johnson Henn, Bradley K. Ervin, Covington & Burling, LLP, Washington, DC, for Shire Pharmaceuticals Inc.

MEMORANDUM OPINION

ROSEMARY M. COLLYER, District Judge.

Actavis Elizabeth LLC seeks judicial review of a decision of the United States Food and Drug Administration awarding five years of market exclusivity to Intervenor-Defendant Shire Pharmaceuticals Inc. for the manufacture of lisdexamfetamine dimesylate ("LDX"), currently marketed by Shire's subsidiary in the United States under the trade name Vyvanse®. Actavis disagrees with the agency's conclusion...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases